TREATMENT OF RECURRENT OVARIAN CANCER

Clinical trials for TREATMENT OF RECURRENT OVARIAN CANCER explained in plain language.

Never miss a new study

Get alerted when new TREATMENT OF RECURRENT OVARIAN CANCER trials appear

Sign up with your email to follow new studies for TREATMENT OF RECURRENT OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for women battling ovarian cancer recurrence

Disease control Recruiting now

This study is testing a new three-part treatment for ovarian cancer that has returned after initial therapy. It combines a novel immunotherapy drug (QL1706) with standard chemotherapy and a targeted anti-cancer pill (anlotinib). The goal is to see if this combination can better c…

Matched conditions: TREATMENT OF RECURRENT OVARIAN CANCER

Phase: PHASE2 • Sponsor: Affiliated Cancer Hospital & Institute of Guangzhou Medical University • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

TREATMENT OF RECURRENT OVARIAN CANCER

Get alerted when new TREATMENT OF RECURRENT OVARIAN CANCER trials appear

New hope for women battling ovarian cancer recurrence